Anas Ahmad
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
Papers in
-
- RNA Interference and Gene Delivery 4
- Biomaterials 16
- Nanoparticle-Based Drug Delivery 16
- Co-authors
- Rehan Khan (51 shared papers)Haseeb Ahsan (4 shared papers)Ajay Kumar (25 shared papers)Mohammad Imran (2 shared papers)Syed Shadab Raza (25 shared papers)Akshay Vyawahare (14 shared papers)Md. Meraj Ansari (19 shared papers)Rakesh Kumar Mishra (4 shared papers)
- Journals
- ACS Biomaterials Science & Engineering (8 papers)Materials Science and Engineering C (4 papers)ACS Omega (3 papers)International Journal of Biological Macromolecules (3 papers)Seminars in Cancer Biology (3 papers)
- Partner nations
- IndiaSaudi ArabiaCanada
In The Last Decade
Anas Ahmad
67 papers receiving 2.1k citations
Anas Ahmad's Hit Papers
Peers
Comparison fields: 5 of 142
- Biomaterials 398
- Pharmaceutical Science 176
- Complementary and alternative medicine 186
- Molecular Medicine 92
- Toxicology 59
Countries citing papers authored by Anas Ahmad
This map shows the geographic impact of Anas Ahmad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anas Ahmad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anas Ahmad more than expected).
Fields of papers citing papers by Anas Ahmad
This network shows the impact of papers produced by Anas Ahmad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anas Ahmad. The network helps show where Anas Ahmad may publish in the future.
Co-authors
The 25 scholars most cited alongside Anas Ahmad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 190 | |
| 2 | Biomarkers as Biomedical Bioindicators: Approaches and Techniques for the Detection, Analysis, and Validation of Novel Biomarkers of Diseases Hit paper breakdown → | 2023 | 161 |
| 3 | 2019 | 139 | |
| 4 | 2020 | 135 | |
| 5 | 2021 | 122 | |
| 6 | 2019 | 117 | |
| 7 | 2022 | 87 | |
| 8 | 2020 | 82 | |
| 9 | 2021 | 77 | |
| 10 | 2022 | 76 | |
| 11 | 2020 | 75 | |
| 12 | 2020 | 59 | |
| 13 | 2019 | 56 | |
| 14 | 2018 | 53 | |
| 15 | 2021 | 52 | |
| 16 | 2018 | 41 | |
| 17 | 2019 | 40 | |
| 18 | 2020 | 33 | |
| 19 | 2021 | 31 | |
| 20 | 2020 | 26 |
About Anas Ahmad
Anas Ahmad is a scholar working on Molecular Biology, Biomaterials, Pharmaceutical Science, Genetics and Biomedical Engineering, having authored 69 papers that have together received 2.1k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (16 papers), Inflammatory Bowel Disease (10 papers), Advanced Drug Delivery Systems (8 papers), Advancements in Transdermal Drug Delivery (7 papers), RNA Interference and Gene Delivery (4 papers), Computational Drug Discovery Methods (4 papers), Curcumin's Biomedical Applications (4 papers) and Graphene and Nanomaterials Applications (4 papers). The work is most often cited by research in Biomaterials (398 citations), Pharmaceutical Science (176 citations), Complementary and alternative medicine (186 citations), Molecular Medicine (92 citations) and Toxicology (59 citations). Anas Ahmad has collaborated with scholars based in India, Saudi Arabia and Canada. Frequent co-authors include Rehan Khan, Haseeb Ahsan, Ajay Kumar, Mohammad Imran, Syed Shadab Raza, Akshay Vyawahare, Md. Meraj Ansari, Rakesh Kumar Mishra, Rakesh K. Mishra and Muneeb U. Rehman. Their work appears in journals such as ACS Biomaterials Science & Engineering, Materials Science and Engineering C, ACS Omega, International Journal of Biological Macromolecules and Seminars in Cancer Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.